Mitochondrial abnormalities in inclusion-body myositis

Area of Science:

• Neurology
• Genetics
• Mitochondrial Biology

Background:

• Mitochondrial abnormalities, including cytochrome c oxidase (COX)-deficient muscle fibers and mitochondrial DNA (mtDNA) deletions, are prevalent in sporadic inclusion-body myositis (s-IBM).
• These COX-deficient fibers result from the clonal expansion of mtDNA deletions and point mutations within specific muscle fiber segments, varying in size.
• The 4977 bp common deletion is a frequent cause, but other deletions also contribute, with breakpoints clustering in specific regions.

Purpose of the Study:

• To investigate the role of mitochondrial DNA deletions and associated genetic factors in sporadic inclusion-body myositis (s-IBM).
• To determine the frequency and characteristics of mitochondrial DNA deletions in s-IBM muscle fibers.
• To explore potential genetic underpinnings in nuclear genes related to mtDNA maintenance in s-IBM.

Main Methods:

• Analysis of muscle fibers for cytochrome c oxidase (COX) deficiency.
• Identification and characterization of mitochondrial DNA (mtDNA) deletions, including the common 4977 bp deletion.
• Mutation screening of nuclear genes POLG1, ANT1, and C10orf2 in s-IBM patients.

Main Results:

• Mitochondrial DNA deletions and COX-deficient muscle fibers are significantly more frequent in s-IBM compared to age-matched controls.
• Clonal expansion of various mtDNA deletions, including the common 4977 bp deletion, underlies the COX-deficient muscle fiber segments.
• No mutations were found in the nuclear genes POLG1, ANT1, and C10orf2 in the analyzed s-IBM patients.

Conclusions:

• Impaired mitochondrial function due to mtDNA deletions likely contributes to muscle weakness and wasting in s-IBM.
• The findings support a significant role for mtDNA instability in the pathogenesis of sporadic inclusion-body myositis.
• Therapeutic strategies effective for other mitochondrial myopathies could be considered for s-IBM treatment.